MIDAS Bi-directional DNA Assembly System for Multigene Construction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing DNA assembly techniques, such as Golden Gate cloning, are unidirectional, limiting the flexibility and speed of constructing multigene assemblies, especially when integrating genes into a chromosome or testing different chromosomal integration sites, as they restrict the order and orientation of gene addition.
Innovation Solution
The Modular Idempotent DNA Assembly System (MIDAS) uses a set of shuttle vectors with specific restriction sites configurations to enable bi-directional assembly of multigene constructs, allowing for flexible control over the order, orientation, and polarity of gene addition through the use of Type IIS restriction enzymes, enabling the assembly of multiple genes in a single vector.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If unidirectional modular assembly systems (such as Golden Gate cloning) are used, then the assembly process is simplified and standardized, but the flexibility and speed of constructing multigene assemblies are limited
Solution Approach 1:
The patent implements bidirectional assembly capability by designing vector systems with multiple assembly circuits that can operate in both directions. The system dynamically adapts the assembly direction based on the desired gene insertion position, allowing genes to be added to either the 5' or 3' end of the multigene assembly. This dynamic flexibility resolves the contradiction by maintaining standardized procedures while enabling versatile construction approaches.
Solution Approach 2:
The patent segments the assembly system into multiple independent circuits with distinct restriction sites and overhang configurations. Each circuit can operate autonomously in a specific direction, and the system can switch between circuits to achieve bidirectional assembly. This segmentation allows the maintenance of standardized assembly protocols within each circuit while providing overall system flexibility.
2Productivity
If unidirectional assembly is used, then the assembly circuit can be kept open for further additions, but the order and orientation of gene addition are restricted
Solution Approach 1:
The patent adds a dimensional aspect to the assembly system by introducing bidirectional capability along the DNA sequence axis. Instead of linear unidirectional assembly, the system enables assembly from both 5' and 3' ends simultaneously, creating a two-directional assembly space. This allows researchers to control gene order and orientation more precisely while maintaining efficient assembly processes.
3Productivity
If site-specific recombination systems are used, then efficient high-throughput construction of multigene assemblies is achieved, but recombination site sequence scars prevent modular design
Solution Approach 1:
The patent extracts and eliminates the problematic recombination site scars by using restriction enzyme-based Type IIS assembly instead of site-specific recombination. The Type IIS enzymes cut outside their recognition sites, allowing the recognition sites to be removed in the final assembly, leaving no scar sequences. This extraction of harmful elements maintains high construction efficiency while enabling true modular design with seamless gene junctions.
4Manufacturing precision
If overlap-directed in vitro assembly methods are used, then scarless assemblies are produced, but new primer sets must be designed for every fragment addition
Solution Approach 1:
The patent performs preliminary action by pre-defining standardized overhang sequences and restriction sites in the vector system. These pre-configured elements allow fragments to be assembled using universal primers and standardized protocols, eliminating the need to design new primer sets for each fragment addition. The preliminary setup of the assembly circuit enables repeatable, scarless assembly operations.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
MIDAS provides a flexible and efficient method for constructing multigene assemblies, overcoming the limitations of unidirectional assembly systems by allowing bi-directional addition of genes and maintaining the assembly circuit open for further additions, facilitating complex pathway reconstruction and expression in heterologous systems.
Implementation Method 1
Golden Gate cloning utilises the ability of Type IIS restriction enzymes, which recognise non-palindromic sequences and cleave at one side of the recognition site, to seamlessly join multiple DNA fragments together in a single (one-pot) reaction
Data Source
AI summary
A modular and hierarchical DNA assembly platform for synthetic biology is described. This enabling technology, termed MIDAS (for Modular Idempotent DNA Assembly System), can precisely assemble multiple DNA fragments in a single reaction using a standardised assembly design. It can be used to build genes from libraries of sequence-verified, reusable parts and to assemble multiple genes in a single vector. We describe the design and use of MIDAS, and its application in the reconstruction of the metabolic pathway for production of paspaline, a key intermediate in the biosynthesis of a range of indole diterpenes—a class of economically important secondary metabolites produced by several species of filamentous fungi.